On the 21st November 2018 Dr Karen Smith hosted a visit by GSK to UEA. 25 UEA academics drawn from across the Schools of Medicine, Biological Sciences, Computing and Pharmacy enjoyed a fascinating visit from the GSK Discovery Partnerships with Academia Unit (DPAc).
The DPAc unit have an innovative approach to drug discovery. Set within GSK’s research and development organization, it is dedicated to creating highly collaborative relationships with leading academic researchers and believes that working closely together and combining the different strengths of the company with academics is a great way to develop new medicines that truly benefit patients. The concept has proved simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise, capabilities and resources needed to make a medicine. The visit was designed to inform UEA researchers about the DPAc model and facilitate networking and discussions of potential collaborations.
Dr John Liddle, Senior Director & Discovery Partnerships Leader, DPAc and Dr Andy Pearce, DPAc Partnership Leader Europe gave a highly informative talk about the programme and answered questions at the end. This was followed by a networking lunch to ensure everyone could speak to John and Andy informally. Prof Laura Bowater kindly introduced the poster session held in the Julian Study Centre.
After lunch our visitors had a series of one-to-one meeting with Prof Michael Wormstone, Dr Sam Fountain, Dr Sean Bew, Dr Mark Williams and Dr Mohammad Hajihosseini.
If you would like to find out more about drug discovery activities at UEA please contact Dr Karen Smith at firstname.lastname@example.org